Mindvalley uvádza na Vision Pro od Apple prvú aplikáciu na meditácie a osobný rozvoj, ktorá vás naplno pohltí

Mindvalley je individuálna pohlcujúca aplikácia na osobný rozvoj, spustená na visionOS App Store  KUALA LUMPUR, Malajzia, LONDÝN, NEW YORK a LOS ANGELES, 3. februára 2024 /PRNewswire/ — Mindvalley, popredná platforma v oblasti osobného rozvoja, s radosťou oznamuje uvedenie svojej prevratnej pohlcujúcej aplikácie na meditáciu a osobný rozvoj na Vision Pro, revolučnej priestorovej počítačovej náhlavnej súprave od … Read more

Arkadia Festival 2023 Fast Approaching–Daily Schedules Announcing October 6

LAS VEGAS, Oct. 6, 2023 /PRNewswire/ — Promising an immersive and uniquely transformative experience, Fit For Service’s ARKADIA: Festival Of A More Beautiful World returns to the mind-bending venue of AREA15 on November 2–5, 2023. The festival lineup features an extraordinary roster of talented artists, visionary speakers, and inspiring workshops, curated to kindle the imagination and … Read more

Four-Legged Caregiver Newest Team Member at St. Joseph’s Children’s Hospital

TAMPA, Fla., June 15, 2023 /PRNewswire/ — St. Joseph’s Children’s Hospital recently welcomed its first-ever facility dog, Revere, a 2-year-old Labrador Golden Retriever mix. Revere is no ordinary dog; he’s a specially trained canine who underwent two years of training and knows more than 40 tasks that allow him to interact with patients and team … Read more


Federal Funding Increases Fuel Research Progress and Help Improve Patient Outcomes LOS ANGELES, June 14, 2023 /PRNewswire/ — The Pancreatic Cancer Action Network (PanCAN), a leading pancreatic cancer patient advocacy organization, today launched its Call on Congress Day campaign, part of its annual advocacy strategy to mobilize pancreatic cancer survivors, caregivers and supporters from around the United … Read more

Novartis Kisqali® significantly reduced the risk of recurrence by 25% across a broad population of patients with early breast cancer; clinically meaningful benefit was consistent across subgroups

Kisqali is the first and only CDK4/6 inhibitor to demonstrate a consistent, clinically meaningful benefit across a broad population of patients with HR+/HER2- early breast cancer, regardless of disease stage, menopausal or nodal status1 Results were also consistent across all secondary endpoints, including distant disease-free survival and recurrence-free survival, with a trend for improved overall … Read more

Kyowa Kirin Continues Commitment to Making Dreams Possible

Global specialty pharmaceutical company supports Dream Foundation’s work to provide comfort, closure, and inspiration at the end of life. BEDMINSTER, N.J. and SANTA BARBARA, Calif., May 30, 2023 /PRNewswire/ — Kyowa Kirin, Inc., an affiliate of Kyowa Kirin. Ltd. (Kyowa Kirin, TSE: 4151), a global specialty pharmaceutical company, has extended its support of Dream Foundation – … Read more

SuperOps.ai Launches Mental Wellness Initiative at Channel Partners Conference & Expo to Support MSPs

Small business owners, including owners of MSPs, are disproportionately affected when it comes to mental health issues, but few seek help. 65% of entrepreneurs have dealt with anxiety. 4 out of 5 small business owners are experiencing poor mental health. The SuperOps.ai #TogetherWeCan initiative sets out to support MSPs, let them know they are not … Read more